Corporate - Media & Press - Press Release
Arrayit Corporation Commences Business Operations from New Sunnyvale Headquarters.
Arrayit Corporation, December 30, 2013 9:05 AM, EST
SUNNYVALE, Calif.--(BUSINESS WIRE)--Arrayit Corporation (OTCBB: ARYC), a life sciences and molecular diagnostics leader, announces today that the company has commenced business operations from its new corporate headquarters located at 927 Thompson Place in Sunnyvale, California, USA. The new corporate headquarters feature expansive modern offices and meeting rooms, R&D, manufacturing, packaging and shipping facilities, and cleanroom laboratories that are currently undergoing class 100 enhancements and certification for Clinical Laboratories Improvement Amendments (CLIA) and International Organization for Standardization (ISO) 9001 and 13485.
Arrayit develops, manufactures, markets, sells and supports patented and proprietary microarray products and services for university laboratories, government agencies, and life sciences, biotechnology, diagnostics and pharmaceutical companies worldwide. The company uses its life sciences tools revenue to fund pre-symptomatic diagnostic testing for major treatable human conditions including ovarian cancer and Parkinson’s Disease. Arrayit OvaDx® for pre-symptomatic ovarian cancer monitoring and screening, is scheduled for United States Food and Drug Administration (FDA) 510(k) submission during the first half of 2014.
Arrayit expects to ship seven life sciences instruments and sixty consumable products totaling $167,000 USD from its newly-opened company headquarters in the remaining two business days of 2013. The revenue and earnings from the $167K shipments will book in the fourth quarter of 2013. Reiterating the guidance provided during the November 15th 2013 conference call, the company expects higher net income for the fourth quarter of 2013 compared to the third quarter, and double-digit revenue growth for the full fiscal year 2013 compared to 2012.
About Arrayit Corporation
Arrayit utilizes its patented and proprietary microarray platform to lead and empower the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.
- Powerful Science for Life
Visit http://arrayit.com/ for more information.
Safe Harbor Statement
We have identified forward-looking statements by using words such as "expect", "believe", and "should". Although we believe our expectations are reasonable, our operations involve a number of risks and uncertainties that are beyond our control, and these statements may turn out not to be true. Risk factors associated with our business, including some of the facts set forth herein, are detailed in the Company's Form 10-K for the fiscal year ended December 31, 2012 and in Form 10-Q for the quarterly period ended September 30, 2013.
Institutional Marketing Services (IMS)
John Nesbett, 203-972-9200
Jennifer Belodeau, 203-972-9200
Copyright 1993-2017 Arrayit Corporation. All rights reserved.